CONFERENCE COVERAGE
American Headache Society
Annual Meeting
2019 COVERAGE
- Opioid Prescription Trends for Migraine in Youth in the ED
- Shift in Prescribing Patterns for Migraine Prophylaxis
- Telemedicine Comparable to In-Office Visits for Migraine Follow-Up Care
- History of Migraine May Not Be Linked to Cardiovascular Events in Postmenopausal Women
- Galcanezumab Ineffective for Chronic Cluster Headache Treatment
- Eptinezumab May Significantly Reduce Migraine-Related Burden
- Promising Results for Lacosamide in the Treatment of Chronic Migraine
- Non-Invasive Device Stimulating Occipital and Trigeminal Nerves Effectively Treats Acute Migraine
- Oral Atogepant May Reduce Mean Monthly Migraine Days
- Single-Dose Rimegepant Provides Rapid, Sustained Relief From Migraine
- Ubrogepant Efficacious in Acute Migraine Treatment if Triptans Not Effective
- OnabotulinumtoxinA Effective, Safe, and Tolerable in Chronic Migraine
Latest Tweets
Follow
@ahsheadache
Conference Coverage from
